Why the Next Recession Will Be the Catalyst for Depression
January 30, 2026
Gold: Record Highs Face Reversal Risk as Fed Signals Rate Pause
January 28, 2026
Global equities stay fragile as oil volatility and Middle East tensions drive sentiment. Brent swings toward $100 keep stocks volatile despite large strategic reserve releases. S&P 500 technical structure remains...
Read moreDetailsfutures are currently trading near $84.50, consolidating after the sharp volatility expansion that recently drove prices from $97.55 highs down to $79.64 lows. Within the VC PMI (Variable Changing Price...
Read moreDetailsOil prices are soaring amid escalating geopolitical tensions in the Middle East. WTI crude recently settled around $95 per barrel, while Brent approached $100. Below, we highlight three undervalued mid-cap...
Read moreDetailsETF inflows and institutional buying support Bitcoin even as short-term volatility persists. Macro factors like Fed policy, inflation data, and liquidity still shape Bitcoin’s direction. A break above $71,900 strengthens...
Read moreDetailsSince the 70s, financial markets have followed relatively predictable patterns. One of the well-known relationships was the inverse correlation between gold and : when rates went up, gold usually fell,...
Read moreDetailsThe fell by 1.5% on Thursday, marking its lowest close since mid-November. At this point, the index has broken support at 6,700, which sets up the next area of support...
Read moreDetailsGlobal equities stay fragile as oil volatility and Middle East tensions drive sentiment. Brent swings toward $100 keep stocks volatile despite large strategic reserve releases. S&P 500 technical structure remains...
Read moreDetailsAfter reviewing the movements of the since the beginning of this month, I anticipate that the gold furthers are persistently sliding since second peak at $5,434 on Mar.2, after post-record...
Read moreDetailsThe problem children of higher US break-even inflation and wider US swap spreads remains problematic – we explore. Overall, market sentiment is not happy with oil testing above $100. Should...
Read moreDetailsCancer remains one of the greatest medical challenges for biotechnology firms, even as the oncology medicine market is expected to surge to $366 billion in the next eight years. Companies...
Read moreDetails









